CATALYSTRESEARCH LABSVAULT

PREVIEW · BATCH DOCUMENTS

Retatrutide 10 mg

Public lot record and Certificate of Analysis for this scan. Research use only — not for human or veterinary use. Order details open after email verify.

LOT
26-RT10-01
BATCH
Verified
PRODUCTS
2
LOTS
2

ACCESS MY ORDER

Add these lots to My Collection.

Use the checkout email. A one-time link opens the item page in the research portal. The same response is sent whether or not the address matches.

Preview only. Live cards send the access link from this form.

IN THIS BATCH

Lots and COAs

Public batch documents. Quantity and shipment stay behind email verify.

  • Retatrutide 10 mg

    CRL-STARTER-RETA-199 · 26-RT10-01

    MATCHED

    Lyophilized. Protect from light. See the Certificate of Analysis.

    OPEN COAPRODUCT NOTES

  • GHK-Cu 100 mg

    CRL-CU100 · 26-CU100-01

    MATCHED

    Lyophilized. Protect from light. See the Certificate of Analysis.

    OPEN COAPRODUCT NOTES

PEPTIDE INFORMATION

What is in this batch.

Research-use notes for the families on this card. A COA confirms identity and purity for the lot — it is not approval for human use.

TRIPLE GIP / GLP-1 / GLUCAGON AGONIST

Retatrutide

An investigational triple agonist. There is no FDA-approved human regimen. Lilly’s Phase 3 TRIUMPH program is the public quantity reference we show.

  • Treat every lot as investigational research material.
  • Do not interpolate a human schedule from the Phase 3 table.
  • Retest date and method live on the COA for this lot.

BPC-157, TB-500, GHK-CU, BLENDS

Research peptides (repair / cosmetic class)

Short research peptides and blends (GLOW, KLOW, GHK-Cu, SNAP-8, and related SKUs). Each line item still resolves to its own lot and COA when one exists.

  • Blends are not a substitute for reading each constituent lot record.
  • Reconstitute lyophilized cakes with bacteriostatic water unless the COA says otherwise.
  • Storage is lot-specific. The card in the box wins over this page.

QUANTITY / DOSING GUIDE

Educational quantity reference.

Educational quantity chart only. Not a use protocol, not medical advice, and not for human or veterinary use. Match every draw to this lot’s Certificate of Analysis.

01

Confirm lot

The vial, the COA, and this Vault card must show the same lot.

02

Choose diluent

Bacteriostatic water from this shipment unless the COA names something else.

03

Record volume

Write the milliliters added and the resulting mg/ml on the insert. Do not guess later.

04

Store per COA

Protect from light. Refrigerate reconstituted material only if the lot record says so.

LOW TO HIGH · WEEKLY AND 4-WEEK QTY

Retatrutide*

Dose levelStarting
Qty per weekly dose2 mg
Qty per 4 weeks8 mg
RolePhase 3 initiation
Dose levelLowest target
Qty per weekly dose4 mg
Qty per 4 weeks16 mg
RolePhase 3 target dose
Dose levelIntermediate
Qty per weekly dose6 mg
Qty per 4 weeks24 mg
RoleEscalation step
Dose levelTarget
Qty per weekly dose9 mg
Qty per 4 weeks36 mg
RolePhase 3 target dose
Dose levelHighest target
Qty per weekly dose12 mg
Qty per 4 weeks48 mg
RolePhase 3 target dose

LOWEST STARTING OPTION

Reta*

Lowest starting dose2 mg
4 doses8 mg
8 doses16 mg
12 doses24 mg

LOWEST MAINTENANCE / TARGET OPTION

Retatrutide*

Lowest maintenance/target option4 mg/week
Per 4 weeks16 mg

* Retatrutide is still investigational as of September 2026 and has no FDA-approved human dosing regimen. Lilly’s Phase 3 TRIUMPH program uses 2, 4, 6, 9 and 12 mg. Research use only.

GLP DIET

GLP research diet notes

Published GLP-1 / dual / triple agonist work often discusses food volume, protein, and GI comfort. This is background for reading papers — not a meal plan and not for human or veterinary use.

Protein-forward

Many protocols pair caloric reduction with higher protein so lean mass is the variable being watched, not an afterthought.

Smaller, slower meals

Incretin literature repeatedly notes earlier satiety and delayed gastric emptying. Large, high-fat boluses are a common confounder in GI adverse-event tables.

Hydration + electrolytes

Nausea and reduced intake show up in trial appendices. Water and sodium/potassium are the usual first notes — not supplements from this shop.

Fiber, then fat

Constipation is a listed incretin effect. Soluble fiber and a consistent meal clock show up more often than “detox” language.

Alcohol and carbonation

Both appear as GI irritants in patient-facing incretin counseling. Treat as noise in any research log.

Log, don’t improvise

If you keep a research logbook, meal timing and GI notes belong next to the lot number — not a separate diet app.

FOR LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN USE · PREVIEW — live lots open from the card in your shipment

ACCESS MY ORDEROPEN COA